| Name | cymarin |
|---|---|
| Synonyms |
3β-[(2,6-Dideoxy-3-O-methyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxo-5β,14β-cd-20-enolide
KOMBETIN CYMIN(P) CYMIN CYMIN //BP strofantidinacimoside MFCD00003669 EINECS 208-087-9 K-STROPHANTHIDIN-D-CYMOSIDE alvonalmr WV-90043a K STROPHANTHIN Cd-20(22)-enolide, 3-[(2,6-dideoxy-3-O-methyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxo-, (3β,5β) K-STROPHANTHIN-A K-STROPHANTHIN-ALPHA CIMARIN STROPHANTHIN K (3beta,5beta)-3-[(2,6-dideoxy-4-O-beta-D-glucopyranosyl-3-O-methyl-beta-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocd-20-enolide 3β-[(3-O-Methyl-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxo-5β-cd-20-enolide CYMINE 20,5BETA-CDENOLID-19-AL-3BETA,5BETA,14BETA-TRIOL 3BETA-MIXED GLYCOSIDES CYMIN CRYSTALLINE CIMIN 5-beta-cd-20-enolide,3-beta-(beta-d-cymosyloxy)-5,14-dihydroxy-19-ox |
| Description | Cymarin, a cardiac glycoside, potently inhibits the Palytoxin (PTX)-induced K+ release (IC50=0.42 μM)[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.31 g/cm3 |
|---|---|
| Boiling Point | 722.1ºCat 760 mmHg |
| Melting Point | 148ºC |
| Molecular Formula | C30H44O9 |
| Molecular Weight | 548.66 |
| Flash Point | 232.7ºC |
| Exact Mass | 548.29900 |
| PSA | 131.75000 |
| LogP | 2.43330 |
| Index of Refraction | 1.589 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS06, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H301 + H331-H373 |
| Precautionary Statements | P261-P301 + P310-P311 |
| Personal Protective Equipment | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
| Hazard Codes | T: Toxic; |
| Risk Phrases | R23/25 |
| Safety Phrases | 45-36/37/39-36/37-28-26 |
| RIDADR | UN 3462 6.1/PG 2 |
| WGK Germany | 3 |
| RTECS | GZ5600000 |
| Packaging Group | III |
| Hazard Class | 6.1(b) |